Skip to main content

Advertisement

SpringerLink
Log in

Obesity and sedentary lifestyle: Modifiable risk factors for prevention of type 2 diabetes

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Over the past 25 years, the prevalence and incidence of type 2 diabetes have increased alarmingly worldwide and across all age, gender, and race/ethnic groups. The high economic costs, resulting from the numerous and severe complications of this disease, as well as the social burden associated with diabetes mellitus, have motivated the pursuit of prevention methods. Recently, clinical and observational studies have demonstrated the adverse effects of obesity and sedentary lifestyle, as well as the benefits of moderate weight loss and related behaviors, including increased levels of physical activity, in maintaining metabolic control and reducing the incidence of type 2 diabetes. The challenge remains to find ways to successfully deliver this message to the communities, and to evaluate the cost-effectiveness of the different delivery approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Rubin R, Altman W, Mendelson D: Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 1994, 78:809A-810F.

    Article  PubMed  CAS  Google Scholar 

  2. American Diabetes Association: Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998, 21:296–309.

    Article  Google Scholar 

  3. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL: Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994, 272:205–211.

    Article  PubMed  CAS  Google Scholar 

  4. Mokdad AH, Ford ES, Bowman BA, et al.: Diabetes trends in the US: 1990-1998. Diabetes Care 2000, 23:1278–1283. Results indicated rapid increases in the prevalence of diabetes (4.9% in 1990 to 6.5% in 1995), which correlated highly with similar increases in rates of obesity.

    Article  PubMed  CAS  Google Scholar 

  5. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21:1414–1431. Supports earlier predictions of the worldwide epidemic nature of diabetes during the first quarter of the 21st century, and provides a provisional picture of its characteristics.

    Article  PubMed  CAS  Google Scholar 

  6. Harris MI, Flegal KM, Cowie CC, et al.: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 1998, 21:518–524.

    Article  PubMed  CAS  Google Scholar 

  7. Mayer-Davis EJ, D’Agostino R Jr, Karter AJ, et al.: Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA 1998, 279:669–674. The significance of this study lies in its findings that increased participation in nonvigorous, as well as overall and vigorous, physical activity was associated with significantly higher insulin sensitivity.

    Article  PubMed  CAS  Google Scholar 

  8. Viswanathan M, Snehalatha C, Viswanathan V, et al.: Reduction in body weight helps to delay the onset of diabetes even in non-obese with strong family history of the disease. Diabetes Res Clin Pract 1997, 35:107–112.

    Article  PubMed  CAS  Google Scholar 

  9. Pan XR, Li GW, Hu YH, et al.: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care 1997, 20:537–544.

    Article  PubMed  CAS  Google Scholar 

  10. Hu FB, Sigal RJ, Rich-Edwards JW, et al.: Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA 1999, 282:1433–1439. Demonstrates the importance of frequent, moderate intensity physical activity in the reduction of risk for type 2 diabetes.

    Article  PubMed  CAS  Google Scholar 

  11. Tuomilehto J, Lindstrom J, Eriksson JG, et al., for the Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343–1350. An excellent clinical trial demonstrating that type 2 diabetes can be prevented by changes in the lifestyles of high-risk individuals.

    Article  PubMed  CAS  Google Scholar 

  12. Edelstein SL, Knowler WC, Bain RP, et al.: Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997, 46:701–710.

    Article  PubMed  CAS  Google Scholar 

  13. Manson JE, Spelsberg A: Primary prevention of noninsulin- dependent diabetes mellitus. Am J Prev Med 1994, 10:172–184.

    PubMed  CAS  Google Scholar 

  14. Sjostrom CD, Lissner L, Weedel H, Sjostrom L: Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999, 5:477–484.

    Google Scholar 

  15. Moore LL, Visioni AJ, Wilson PW, et al.: Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus? Epidemiology 2000, 3:269–273. Study findings indicate that a modest amount of sustained weight loss can substantially reduce the risk of diabetes mellitus in overweight individuals, even in the absence of intensive support of a clinical trial intervention.

    Article  Google Scholar 

  16. Eriksson KF, Lindgarde F: Prevention of type 2 (non-insulin dependent) diabetes mellitus by diet and physical exercise. Diabetologia 1991, 34:891–898.

    Article  PubMed  CAS  Google Scholar 

  17. Heymsfield SB, Segal KR, Hauptman J, et al.: Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 2000, 160:1321–1326.

    Article  PubMed  CAS  Google Scholar 

  18. Wannamethee SG, Shaper AG: Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 1999, 22:1266–1272. Confirms the critical importance of overweight and obesity, particularly of long duration, in the development of type 2 diabetes.

    Article  PubMed  CAS  Google Scholar 

  19. Uusitupa M, Louheranta A, Lindstrom J, et al.: The Finnish Diabetes Prevention Study. Br J Nutr 2000, 83(suppl 1): S137-S142.

    PubMed  CAS  Google Scholar 

  20. The Diabetes Prevention Program Research Group: The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 1999, 22:623–634.

    Article  Google Scholar 

  21. Folsom AR, Jacobs DR, Wagenknecht LE, et al.: Increase in fasting insulin and glucose over seven years with increasing weight and inactivity of young adults. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol 1996, 144:235–246.

    PubMed  CAS  Google Scholar 

  22. Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS Jr: Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991, 325:147–152.

    Article  PubMed  CAS  Google Scholar 

  23. Manson JE, Rimm EB, Stampfer MJ, et al.: Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 1991, 338:774–778.

    Article  PubMed  CAS  Google Scholar 

  24. Manson JE, Nathan D, Stampfer MJ, et al.: A prospective study of exercise and incidence of diabetes in U.S. male physicians [abstract]. Diabetes 1992, 41:128A.

    Google Scholar 

  25. Knowler WC, Pettitt DJ, Savage PJ, Bennett PH: Diabetes in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol 1981, 113:144–156.

    PubMed  CAS  Google Scholar 

  26. Franz MJ, Bantle JP, Beebe CA, et al.: Evidence-based nutrition recommendations for the treatment and prevention of diabetes and complications (technical review). Diabetes Care 2001, in press.

  27. American Diabetes Association: Evidence-based nutrition recommendations for the treatment and prevention of diabetes and complications (position statement). Diabetes Care 2001, in press.

  28. Shaten BJ, Smith GD, Kuller LH, Neaton JD: Risk factors for the development of type II diabetes among men enrolled in the usual care group of the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16:1331–1339.

    Article  PubMed  CAS  Google Scholar 

  29. Thomas F, Balkau B, Vauzelle-Kervroedan F, Papoz L: Maternal effect and familial aggregation in NIDDM. The CODIAB Study. CODIAB-INSERM-ZENECA Study Group. Diabetes 1994, 43:63–67.

    Article  PubMed  CAS  Google Scholar 

  30. Fujimoto WY: Overview of non-insulin-dependent diabetes mellitus (NIDDM) in different population groups. Diabet Med 1996, 13(9 suppl 6):S7-S10.

    PubMed  CAS  Google Scholar 

  31. Fujimoto WY, Bergstrom RW, Boyko EJ, et al.: Type 2 diabetes and the metabolic syndrome in Japanese Americans. Diabetes Res Clin Pract 2000, 50(suppl 2):S73-S76.

    Article  PubMed  Google Scholar 

  32. Brancati FL, Kao WH, Folsom AR, et al.: Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 2000, 283:2253–2259.

    Article  PubMed  CAS  Google Scholar 

  33. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group [no authors listed]. Diabetes Care 2000, 23:1619–1629.

  34. Chan JM, Rimm EB, Colditz GA, et al.: Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994, 17:961–969.

    Article  PubMed  CAS  Google Scholar 

  35. Colditz GA, Willett WC, Stampfer MJ, et al.: Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990, 132:501–513.

    PubMed  CAS  Google Scholar 

  36. WHO: Obesity-preventing and managing the global epidemic. Rep WHO Consult Obes WHO/NUT/NCD/98.1. Geneva, Switzerland: World Health Organization; 1994.

    Google Scholar 

  37. Dowse GK, Zimmet PZ, Gareeboo H, et al.: Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care 1991, 14:271–282.

    Article  PubMed  CAS  Google Scholar 

  38. Brown SA, Upchurch S, Anding R, et al.: Promoting weight loss in type II diabetes. Diabetes Care 1996, 19:613–624.

    Article  PubMed  CAS  Google Scholar 

  39. Eriksson J, Lindstrom J, Valle T, et al.: Prevention of type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention program. Diabetologia 1999, 42:793–801.

    Article  PubMed  CAS  Google Scholar 

  40. Klem ML, Wing RR, McGuire MT, et al.: A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr 1997, 66:239–246.

    PubMed  CAS  Google Scholar 

  41. Williams KV, Mullen ML, Kelley DE, Wing RR: The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care 1998, 21:2–15.

    Article  PubMed  CAS  Google Scholar 

  42. Wing RR: Use of very-low-calorie diets in the treatment of obese persons with non-insulin dependent diabetes mellitus. J Am Diet Assoc 1995, 95:569–672.

    Article  PubMed  CAS  Google Scholar 

  43. Wing RR: Physical activity in the treatment of the adulthood overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 1999, 31(suppl 11):S547-S552.

    PubMed  CAS  Google Scholar 

  44. Apfelbaum M, Vague P, Ziegler O, et al.: Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med 1999, 106:179–184.

    Article  PubMed  CAS  Google Scholar 

  45. Hauptman J, Lucas C, Boldrin MN, et al.: Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med 2000, 9:160–167.

    Article  PubMed  CAS  Google Scholar 

  46. Rossner S, Sjostrom L, Noack R, et al.: Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res 2000, 8:49–61.

    Article  PubMed  CAS  Google Scholar 

  47. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health [no authors listed]. Obes Res 1998, 6(suppl 2):51S–209S.

  48. Swinburn BA, Metcalf PA, Ley SJ: Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care 2001, 24:619–624.

    Article  PubMed  CAS  Google Scholar 

  49. Wing RR, Goldstein MG, Acton KJ, et al.: Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care 2001, 24:117–123.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Biostatistics, Norman J. Arnold School of Public Health, University of South Carolina, Carolina Plaza, Room 229, 29208, Columbia, SC, USA

    Elizabeth J. Mayer-Davis PhD & Tina Costacou MSc

Authors
  1. Elizabeth J. Mayer-Davis PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tina Costacou MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mayer-Davis, E.J., Costacou, T. Obesity and sedentary lifestyle: Modifiable risk factors for prevention of type 2 diabetes. Curr Diab Rep 1, 170–176 (2001). https://doi.org/10.1007/s11892-001-0030-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-001-0030-x

Keywords

Search

Navigation